Takeda's Partner Merges With Crestovo to Form Finch Therapeutics Group Post author:Sam Post published:October 22, 2017 Post category:BioPharma Two privately-held biotechs have merged to tackle recurrent C. difficile infections. Source: BioSpace You Might Also Like Zoetis Announces Second Quarter 2017 Results August 7, 2017 FDA Berates Pfizer Unit for EpiPen Misfires During 'Life-Threatening Emergencies' September 7, 2017 Immunovaccine Appoints Seasoned Financial Executive As CFO February 2, 2017
